ClearBridge Investments’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Buy |
+312,445
| New | +$19.7M | 0.02% | 418 |
|
|
2024
Q4 | – | Sell |
-87,424
| Closed | -$4.58M | – | 741 |
|
|
2024
Q3 | $4.58M | Sell |
87,424
-684
| -0.8% | -$35.8K | ﹤0.01% | 583 |
|
|
2024
Q2 | $3.62M | Sell |
88,108
-1,896
| -2% | -$77.8K | ﹤0.01% | 600 |
|
|
2024
Q1 | $3.9M | Sell |
90,004
-1,154
| -1% | -$50K | ﹤0.01% | 598 |
|
|
2023
Q4 | $4.19M | Sell |
91,158
-91,667
| -50% | -$4.21M | ﹤0.01% | 594 |
|
|
2023
Q3 | $4.19M | Buy |
+182,825
| New | +$4.19M | ﹤0.01% | 553 |
|
|
2020
Q3 | – | Sell |
-724
| Closed | -$16K | – | 952 |
|
|
2020
Q2 | $16K | Hold |
724
| – | – | ﹤0.01% | 863 |
|
|
2020
Q1 | $11K | Sell |
724
-24
| -3% | -$365 | ﹤0.01% | 941 |
|
|
2019
Q4 | $17K | Hold |
748
| – | – | ﹤0.01% | 973 |
|
|
2019
Q3 | $16K | Sell |
748
-30,047
| -98% | -$643K | ﹤0.01% | 961 |
|
|
2019
Q2 | $677K | Hold |
30,795
| – | – | ﹤0.01% | 680 |
|
|
2019
Q1 | $844K | Buy |
30,795
+3
| +0% | +$82 | ﹤0.01% | 687 |
|
|
2018
Q4 | $828K | Sell |
30,792
-15
| -0% | -$403 | ﹤0.01% | 700 |
|
|
2018
Q3 | $899K | Sell |
30,807
-47
| -0.2% | -$1.37K | ﹤0.01% | 732 |
|
|
2018
Q2 | $964K | Sell |
30,854
-7,410
| -19% | -$232K | ﹤0.01% | 650 |
|
|
2018
Q1 | $761K | Buy |
38,264
+36,476
| +2,040% | +$725K | ﹤0.01% | 653 |
|
|
2017
Q4 | $52K | Buy |
+1,788
| New | +$52K | ﹤0.01% | 845 |
|